News Announcement

Prism Medico and Pharmacy: Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.

Dear Sir/Madam With reference to the captioned subject please find the attached report on investor complaints for the quarter ended 30th September 2025.You are requested to kindly take the same on record and acknowledge receipt. Thanking You.

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.